Apex Healthcare Limited
Overview
Apex Healthcare Limited is a pharmaceutical company headquartered in Bhadkodra, India, founded in 2002, with 201-500 employees.
Active pharmaceutical ingredients supplied
Substances Apex Healthcare Limited is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Apex Healthcare Limited holds 10 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- ROPIVACAINE HYDROCHLORIDE USPActive2025-12-15
- BUPIVACAINE HYDROCHLORIDE USPActive2025-08-21
- ACYCLOVIR USPActive2025-07-23
- PRILOCAINE USPActive2025-06-04
- MELOXICAM USPActive2024-05-06
- LIDOCAINE HYDROCHLORIDE USPActive2023-12-01
- PIROXICAM USPActive2022-02-25
- BENZOCAINE USPActive2022-02-03
- BISACODYL USPActive2022-01-27
- LIDOCAINE USPActive2019-09-21
- LIDOCAINE HYDROCHLORIDE USPInactive2020-12-15
- BENZOCAINE USPInactive2019-10-16
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Apex Healthcare Limited in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Apex Healthcare Limited? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.